Rivaroxaban labels and packages

Rivaroxaban
XARELTO® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Rivaroxaban
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Labels and Packages

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label

NDC 50458-580-30 30 Tablets

Xarelto® (rivaroxaban) Tablets 10 mg

Rx only

janssen

PRINCIPAL DISPLAY PANEL - 15 mg Tablet Bottle Label

NDC 50458-578-30 30 Tablets

Xarelto® (rivaroxaban) Tablets 15 mg

Dispense the accompanying Medication Guide to each patient.

janssen

Rx only

PRINCIPAL DISPLAY PANEL - 20 mg Tablet Bottle Label NDC 50458-579-30 30 Tablets

Xarelto® (rivaroxaban) Tablets 20 mg

Dispense the accompanying Medication Guide to each patient.

janssen

Rx only

References

Adapted from the FDA Package Insert.